[{"address1": "2625 Townsgate Road", "address2": "Suite 230", "city": "Westlake Village", "state": "CA", "zip": "91361", "country": "United States", "phone": "805 267 9889", "website": "https://www.genelux.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small cell lung cancer. The company is also developing V2ACT Immunotherapy for treating pancreatic cancer. Genelux Corporation has a licensing agreement with ELIAS Animal Health, LLC for V-VET1, a clinical stage animal health product candidate. The company was incorporated in 2001 and is headquartered in Westlake Village, California.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas  Zindrick J.D.", "age": 65, "title": "Chairman, CEO & President", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 570990, "exercisedValue": 0, "unexercisedValue": 11528577}, {"maxAge": 1, "name": "Mr. Matthew  Pulisic M.B.A.", "age": 40, "title": "CFO and Principal Financial & Accounting Officer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph  Cappello Ph.D.", "age": 67, "title": "Chief Technical Officer", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 213077, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean  Ryder J.D.", "age": 55, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 380000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yong  Yu Ph.D.", "age": 53, "title": "Senior Vice President of Clinical Development", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 242615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Paul  Scigalla M.D., Ph.D.", "age": 79, "title": "Chief Medical Officer", "yearBorn": 1945, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ralph  Smalling B.Sc.", "age": 67, "title": "VP & Head of Regulatory Affairs", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.7, "open": 3.68, "dayLow": 3.63, "dayHigh": 3.9, "regularMarketPreviousClose": 3.7, "regularMarketOpen": 3.68, "regularMarketDayLow": 3.63, "regularMarketDayHigh": 3.9, "payoutRatio": 0.0, "beta": -1.461, "forwardPE": -4.132979, "volume": 39830, "regularMarketVolume": 39830, "averageVolume": 220086, "averageVolume10days": 132120, "averageDailyVolume10Day": 132120, "bid": 3.84, "ask": 3.9, "bidSize": 1, "askSize": 1, "marketCap": 134180904, "fiftyTwoWeekLow": 1.6, "fiftyTwoWeekHigh": 6.5, "priceToSalesTrailing12Months": 16772.613, "fiftyDayAverage": 3.8298, "twoHundredDayAverage": 2.7755, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 94169952, "profitMargins": 0.0, "floatShares": 27546830, "sharesOutstanding": 34538200, "sharesShort": 2449398, "sharesShortPriorMonth": 1866176, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0709, "heldPercentInsiders": 0.16583, "heldPercentInstitutions": 0.14123, "shortRatio": 9.77, "shortPercentOfFloat": 0.0841, "impliedSharesOutstanding": 34538200, "bookValue": 0.97, "priceToBook": 4.0051546, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -27660000, "trailingEps": -0.94, "forwardEps": -0.94, "enterpriseToRevenue": 11771.244, "enterpriseToEbitda": -3.284, "52WeekChange": -0.40322578, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 3.885, "targetHighPrice": 30.0, "targetLowPrice": 8.0, "targetMeanPrice": 18.4, "targetMedianPrice": 19.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 34057000, "totalCashPerShare": 0.999, "ebitda": -28676000, "totalDebt": 2039000, "quickRatio": 6.131, "currentRatio": 6.475, "totalRevenue": 8000, "debtToEquity": 6.162, "revenuePerShare": 0.0, "returnOnAssets": -0.48675, "returnOnEquity": -0.96849996, "grossProfits": 8000, "freeCashflow": -13646875, "operatingCashflow": -23836000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -3618.625, "financialCurrency": "USD", "symbol": "GNLX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Genelux Corporation", "longName": "Genelux Corporation", "regularMarketTime": 1742413466, "exchange": "NCM", "messageBoardId": "finmb_11172383", "market": "us_market", "corporateActions": [], "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "regularMarketChangePercent": 4.9999986, "regularMarketPrice": 3.885, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1674743400000, "regularMarketChange": 0.18499994, "regularMarketDayRange": "3.63 - 3.9", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 220086, "fiftyTwoWeekLowChange": 2.2849998, "fiftyTwoWeekLowChangePercent": 1.4281249, "fiftyTwoWeekRange": "1.6 - 6.5", "fiftyTwoWeekHighChange": -2.615, "fiftyTwoWeekHighChangePercent": -0.4023077, "fiftyTwoWeekChangePercent": -40.32258, "epsTrailingTwelveMonths": -0.94, "epsForward": -0.94, "epsCurrentYear": -0.8875, "priceEpsCurrentYear": -4.377465, "fiftyDayAverageChange": 0.0552001, "fiftyDayAverageChangePercent": 0.014413312, "twoHundredDayAverageChange": 1.1094999, "twoHundredDayAverageChangePercent": 0.39974776, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-01-26", "cryptoTradeable": false, "displayName": "Genelux", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]